Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2026-02-01 @ 8:09 AM
Study NCT ID:
NCT02249702
Status:
COMPLETED
Last Update Posted:
2017-12-06
First Post:
2014-09-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma
Sponsor:
Mario Negri Institute for Pharmacological Research
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TAUL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |